Your browser doesn't support javascript.
loading
Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma.
Huang, Xiao; Ding, Qingqing; Guo, Hua; Gong, Yun; Zhao, Jun; Zhao, Min; Sui, Dawen; Wu, Yun; Chen, Hui; Liu, Hui; Zhang, Jinxia; Resetkova, Erika; Moulder, Stacy L; Wang, Wei-Lien; Huo, Lei.
Afiliación
  • Huang X; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Ding Q; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Guo H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Gong Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Zhao J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Zhao M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Sui D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Wu Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Chen H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Liu H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Zhang J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Resetkova E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Moulder SL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
  • Huo L; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States. Electronic address: leihuo@mdanderson.org.
Hum Pathol ; 108: 42-50, 2021 02.
Article en En | MEDLINE | ID: mdl-33221342
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunohistoquímica / Biomarcadores de Tumor / Antígeno B7-H1 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunohistoquímica / Biomarcadores de Tumor / Antígeno B7-H1 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos